HRDIL yields 1000000.00% · JNJ yields 2.13%● Live data
📍 HRDIL pulled ahead of the other in Year 1
Combined, HRDIL + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HRDIL + JNJ for your $10,000?
Here Media Inc. offers original programming content tailored for the lesbian, gay, bisexual, and transgender (LGBT) community on a subscription basis. The company publishes magazines and books, as well as operates companion Websites targeting the LGBT community. Its products include the magazines Out, The Advocate, and HIVPlus, as well as books published by Alyson Books, which are distributed through traditional newsstands, other retail outlets, and by subscriptions of print and digital editions of the magazines. It also operates PlanetOut, an online media company serving the LGBT community through its website Gay.com, a social networking Website; and a companion Website, heretv.com that features original shows, podcasts, news, and other entertainment, as well as a library of LGBT-themed streaming video. In addition, the company provides subscription video-on-demand and/or regularly scheduled television channel services through cable, satellite, and fiber-optic television providers serving domestic television households in the United States; and syndicates free-to-the-user content to Websites, including msn.com and aol.com. It serves customers through cable television, direct-to-home satellite television, fiber-optic television, and the Internet under the brand name "here!". The company is was founded in 2009 and is headquartered in Los Angeles, California.
Full HRDIL Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.